CCM Clinical Research Group
Improving Clinical Trials with a Personal Touch

Researchers have long dedicated themselves to unraveling the mysteries of Alzheimer’s disease and finding an effective treatment. While their mission is to discover a cure, they face challenges within the rigorous process of conducting clinical trials.

However, a hope is on the horizon. The CCM Clinical Research Group is at the forefront of innovative Alzheimer’s research, taking a fresh approach by exploring the genetic components of the disease.
With its groundbreaking work, CCM offers new possibilities for understanding and detecting Alzheimer’s at earlier stages, before symptoms appear. This is a significant step forward in the fight against Alzheimer’s, providing hope for millions of people affected by the disease. It proposes testing the family members of patients to give clinical trials more time to operate and potentially save countless lives.

“What sets us apart from other trials is our focus on detecting Alzheimer’s early on and preventing it from progressing. By targeting young adults and the immediate family of those with advanced Alzheimer’s, we can better screen people likely to develop the disease and prevent it on time,” says Maria Gallagher, CEO of CCM Clinical Research Group.

To this end, CCM has developed advanced testing capabilities that can significantly decrease the number of Americans who develop and suffer from the disease. Its cutting-edge testing protocols and personalized approach pave the way for a future where Alzheimer’s is no longer devastating, but a manageable condition.

Leveraging Capabilities that Create a Real Impact

This excellence in Alzheimer’s trials is complemented by CCM’s extensive experience in the pharmaceutical industry, which helps deliver a suite of services that supports a wide range of clinical trials for pharmaceutical and biotech companies. The group leaves no stone unturned, offering end-to-end services that include design, site selection, patient recruitment, regulatory compliance, data management, and statistical analysis. Due to an expert team of clinicians with over 70 years of combined experience in the medical field, it has a track record of delivering high-quality results and meeting timelines.

It also possesses deep knowledge and experience in conducting clinical trials that involve using medical devices. It works closely with medical device companies to design and conduct trials that evaluate their safety and efficacy. Its expertise in a range of medical specialties, such as cardiology, gastroenterology, and neurology, is unmatched. This enables CCM to offer premium clinical research services to bring new and innovative drugs to the market for depression, hypertension, and diabetes, along with its primary focus—Alzheimer’s disease.

Transforming Treatment with Personalized Care

CCM adopts a customized and family-oriented approach to clinical research on Alzheimer’s, which attracts many new patients and fosters long-term relationships.
This approach enables CCM to take its trials beyond standard clinical research practices. This is primarily based on the understanding that clinical research on Alzheimer’s is about more than just medicine; it’s about making a positive impact on future generations. CCM prides itself on providing exceptional care, and its motto, “Fostering Today a Better Tomorrow,” embodies this dedication to not just treating patients, but improving lives for the better.
CCM has been involved in many clinical trials for Alzheimer’s, and because of its superior care model, the results have been overwhelmingly positive. All patients who participated in these clinical trials have experienced significant improvements, inspiring the next generation to join. This was echoed in a recent trial where a patient improved so dramatically that his daughter was inspired to participate in the next phase. This highlights the farreaching impact of CCM’s clinical research approach, which plays a pivotal role in generating positive outcomes for diagnoses that have a significant impact on countless individuals worldwide.

“This is particularly important as Alzheimer’s tends to run in families. By helping a person stay healthy or prevent the disease, we’re potentially saving the entire family from the devastating effects of Alzheimer’s,” says Gallagher.

Giving CCM an edge is its focus on spirituality and happiness in patient care, in addition to its familyoriented approach. The CCM team prioritizes creating a welcoming and supportive environment for subjects, resulting in enhanced retention rates and positive feedback from patients and sponsors. It is also praised for its professionalism and attentiveness, with many staff members working with the firm since its inception.

Powering Patient-Centered Care and Long-Term Retention

These successes are a testament to the team’s unwavering dedication and exceptional quality of work. Founded by Gallagher and her partner, Issis Corripio—who serves as CCM’s CRC administrator, regulatory, and coordinator—it has grown significantly and established a robust industry reputation. The founders’ personal experience with dementia, with every member having at least one sufferer in their family, has driven their passion for finding a solution for Alzheimer’s disease. This personal connection to their work adds a higher level of motivation and dedication to their mission.

“CCM is currently involved in many studies, with Alzheimer’s being our focus. In addition, we are working on schizophrenia, depression, and COVID-19 studies,” adds Gallagher.

Given the pressing issue in the current climate, CCM is committed to developing medications that prevent COVID-19 and minimize its long-term effects. With a focus on mental health and COVID-19 research, it is dedicated to improving the health and well-being of individuals and communities. Its psychiatry focus has also allowed it to provide important data for mental health trials, which is highly important due to the increasing prevalence of mental health issues in today’s society.

CCM’s commitment to maintaining a high standard of excellence enables the team to produce exceptional results and provide reliable data to its sponsors. Their honesty, hard work, and involvement in the community have contributed to its strong integrity, underscoring its dedication to delivering top-notch services. It works closely on each trial and protocol with a dynamic and collaborative approach to ensure success. As clinical trials become more dynamic and virtual, patients have more opportunities to participate without having to come to the site. CCM’s amazing doctors are dedicated to their craft and care about patients, striving for positive outcomes.

By ensuring an excellent reputation with pharmaceutical companies and maintaining good patient relationships in the trials, CCM ensures compliance and improves retention. It is committed to providing quality care for patients while contributing to advancing medical research. CCM’s professionalism, positivity, and focus on spirituality set it apart from other clinical research companies and make it a valuable asset in the medical field.